Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | CASP1 | P29466 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | CASP7 | P55210 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | DRD4 | P21917 | 1/20 | 0.46 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4868930 | 0.94 | MAPT (0.49) | MAPTKDM4EGAAALDH1A1HSD17B10 | |
| SCHEMBL21707873 | 0.92 | MAPT (0.47) | MAPTKDM4EGAAALDH1A1HSD17B10 | |
| SCHEMBL12461 | 0.88 | DRD2 (0.59) | MAPTKDM4EGAAALDH1A1HSD17B10 | |
| SCHEMBL3111834 | 0.84 | MAPT (0.50) | MAPTKDM4EGAAALDH1A1HSD17B10 | |
| SCHEMBL30634161 | 0.84 | MAPT (0.50) | MAPTKDM4EGAAALDH1A1HSD17B10 | |
| SCHEMBL18770167 | 0.81 | MAPT (0.43) | MAPTKDM4EGAAALDH1A1HSD17B10 | |
| SCHEMBL115559 | 0.81 | KDM4E (0.46) | MAPTKDM4EGAAALDH1A1HSD17B10 | |
| Quinoline SCHEMBL28174132 | 0.81 | ALDH1A1 (0.49) | MAPTKDM4EGAAALDH1A1HSD17B10 | |
| SCHEMBL5467021 | 0.78 | MAPT (0.49) | MAPTKDM4EGAAALDH1A1HSD17B10 | |
| SCHEMBL20647077 | 0.77 | MAPT (0.50) | MAPTKDM4EGAAALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 808 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119931978-A | Application of monoamine oxidase as catalyst in preparation of quinoline nitrogen heterocyclic compound | 河北工业大学 | 2025-05-06 | — | — | CN | claimed |
| CN-117229275-B | Novel 2-acetamido thiazole compound and preparation method and application thereof | 北京中医药大学 | 2024-06-18 | — | — | CN | claimed |
| CN-115595096-B | Anaerobic adhesive and preparation method thereof | 迪马新材料科技（苏州）有限公司 | 2024-03-12 | — | — | CN | claimed |
| CN-115160962-B | Anaerobic sealant and preparation method thereof | 硕德半导体技术(苏州)有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-116376858-A | Application of monoamine oxidase from microorganism as catalyst in preparation of quinoline or quinoline derivative | 浙江大学杭州国际科创中心 | 2023-07-04 | — | — | CN | claimed |
| US-20230093639-A1 | PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT | FIRMENICH SA (CH) | 2023-03-23 | — | — | US | claimed |
| EP-4084769-A1 | PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT | Firmenich SA (CH) | 2022-11-09 | — | — | EP | claimed |
| WO-2021214205-A1 | PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT | FIRMENICH SA (CH) | 2021-10-28 | — | — | WO | claimed |
| CN-109529907-B | Nitrogen-doped carbon material supported cobalt catalyst, preparation method thereof and application thereof in catalytic oxidation of N-heterocyclic compound | 中南民族大学 | 2021-10-15 | — | — | CN | claimed |
| CN-107445891-B | Method for catalyzing carbon-hydrogen bond alkylation reaction of aromatic amine | 苏州大学 | 2020-04-10 | — | — | CN | claimed |
| CN-1500477-A | Quick result aerosol with plant aroma and its preparation | 丛繁滋 | 2004-06-02 | — | — | CN | claimed |
| CN-1475204-A | Medicinal Composition, dry powder vapor, nebula, nebula auxiliary preparation for use through mouth and nose and its preparation method | 丛繁滋 | 2004-02-18 | — | — | CN | claimed |
| US-20030191307-A1 | 2,4-Diaminopyrimidine compounds useful as immunosuppressants | BLUMENKOPF TODD A (US) | 2003-10-09 | — | — | US | claimed |
| US-6369248-B1 | HYDROXY ESTERS FOR PERFUMES | GIVAUDAN SA (CH) | 2002-04-09 | — | — | US | claimed |
| EP-0989970-A1 | FRAGRANCE PRECURSOR COMPOUNDS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 2000-04-05 | — | — | EP | claimed |
| EP-0980863-A1 | Oxime carboxylic acid derivatives | Givaudan Roure (International) S.A. (CH) | 2000-02-23 | — | — | EP | claimed |
| WO-1998058899-A1 | FRAGRANCE PRECURSOR COMPOUNDS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-12-30 | — | — | WO | claimed |
| CN-1059937-A | The production method of technology of fragrant fur | FUR MILL ZHUCHENG CITY (CN) | 1992-04-01 | — | — | CN | claimed |
| US-4460760-A | ADHESIVES | OKURA KOGYO KABUSHIKI KAISHA (JP) | 1984-07-17 | — | — | US | claimed |
| US-4447563-A | Anaerobically curable composition and process for preparation thereof | OKURA KOGYO KABUSHIKI KAISHA (JP) | 1984-05-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030191307-A1 | 2,4-Diaminopyrimidine compounds useful as immunosuppressants | CCR1, AOC1, NOD1 | MAPT 4588/4885KDM4E 2949/4885GAA 3686/4885 |
| US-20230093639-A1 | PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT | PORCN, FAAH2, FASN | MAPT 2828/4885KDM4E 3235/4885GAA 2375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.